Search
Close this search box.
×
Search
[custom_company_search_form]
Lithium
45.35
0.11%
Gold
2,666.70
0.5%
Copper
4.13
(0.47%)
Oil
70.09
1.52%
Bitcoin
97,148.60
2.97%
FTSE 100
8,128.31
0.53%
Nikkei 225
38,026.17
(0.85%)
Dow Jones
43,475.71
(0.14%)
Iron Ore
102.15
1.11%
USD/AUD
0.65
0.3%
Hang Seng
19,601.11
(0.23%)
Lithium
45.35
0.11%
Gold
2,666.70
0.5%
Copper
4.13
(0.47%)
Oil
70.09
1.52%
Bitcoin
97,148.60
2.97%
FTSE 100
8,128.31
0.53%
Nikkei 225
38,026.17
(0.85%)
Dow Jones
43,475.71
(0.14%)
Iron Ore
102.15
1.11%
USD/AUD
0.65
0.3%
Hang Seng
19,601.11
(0.23%)
Lithium
45.35
0.11%
Gold
2,666.70
0.5%
Copper
4.13
(0.47%)
Oil
70.09
1.52%
Bitcoin
97,148.60
2.97%
FTSE 100
8,128.31
0.53%
Nikkei 225
38,026.17
(0.85%)
Dow Jones
43,475.71
(0.14%)
Iron Ore
102.15
1.11%
USD/AUD
0.65
0.3%
Hang Seng
19,601.11
(0.23%)
Lithium
45.35
0.11%
Gold
2,666.70
0.5%
Copper
4.13
(0.47%)
Oil
70.09
1.52%
Bitcoin
97,148.60
2.97%
FTSE 100
8,128.31
0.53%
Nikkei 225
38,026.17
(0.85%)
Dow Jones
43,475.71
(0.14%)
Iron Ore
102.15
1.11%
USD/AUD
0.65
0.3%
Hang Seng
19,601.11
(0.23%)
Lithium
45.35
0.11%
Gold
2,666.70
0.5%
Copper
4.13
(0.47%)
Oil
70.09
1.52%
Bitcoin
97,148.60
2.97%
FTSE 100
8,128.31
0.53%
Nikkei 225
38,026.17
(0.85%)
Dow Jones
43,475.71
(0.14%)
Iron Ore
102.15
1.11%
USD/AUD
0.65
0.3%
Hang Seng
19,601.11
(0.23%)
Lithium
45.35
0.11%
Gold
2,666.70
0.5%
Copper
4.13
(0.47%)
Oil
70.09
1.52%
Bitcoin
97,148.60
2.97%
FTSE 100
8,128.31
0.53%
Nikkei 225
38,026.17
(0.85%)
Dow Jones
43,475.71
(0.14%)
Iron Ore
102.15
1.11%
USD/AUD
0.65
0.3%
Hang Seng
19,601.11
(0.23%)
Lithium
45.35
0.11%
Gold
2,666.70
0.5%
Copper
4.13
(0.47%)
Oil
70.09
1.52%
Bitcoin
97,148.60
2.97%
FTSE 100
8,128.31
0.53%
Nikkei 225
38,026.17
(0.85%)
Dow Jones
43,475.71
(0.14%)
Iron Ore
102.15
1.11%
USD/AUD
0.65
0.3%
Hang Seng
19,601.11
(0.23%)
Lithium
45.35
0.11%
Gold
2,666.70
0.5%
Copper
4.13
(0.47%)
Oil
70.09
1.52%
Bitcoin
97,148.60
2.97%
FTSE 100
8,128.31
0.53%
Nikkei 225
38,026.17
(0.85%)
Dow Jones
43,475.71
(0.14%)
Iron Ore
102.15
1.11%
USD/AUD
0.65
0.3%
Hang Seng
19,601.11
(0.23%)
Lithium
45.35
0.11%
Gold
2,666.70
0.5%
Copper
4.13
(0.47%)
Oil
70.09
1.52%
Bitcoin
97,148.60
2.97%
FTSE 100
8,128.31
0.53%
Nikkei 225
38,026.17
(0.85%)
Dow Jones
43,475.71
(0.14%)
Iron Ore
102.15
1.11%
USD/AUD
0.65
0.3%
Hang Seng
19,601.11
(0.23%)
Lithium
45.35
0.11%
Gold
2,666.70
0.5%
Copper
4.13
(0.47%)
Oil
70.09
1.52%
Bitcoin
97,148.60
2.97%
FTSE 100
8,128.31
0.53%
Nikkei 225
38,026.17
(0.85%)
Dow Jones
43,475.71
(0.14%)
Iron Ore
102.15
1.11%
USD/AUD
0.65
0.3%
Hang Seng
19,601.11
(0.23%)

Stock Piper AI Index

Stock Piper AI Index

Subscribe
Lithium
45.35
0.11%
Gold
2,666.70
0.5%
Copper
4.13
(0.47%)
Oil
70.09
1.52%
Bitcoin
97,148.60
2.97%
FTSE 100
8,128.31
0.53%
Nikkei 225
38,026.17
(0.85%)
Dow Jones
43,475.71
(0.14%)
Iron Ore
102.15
1.11%
USD/AUD
0.65
0.3%
Hang Seng
19,601.11
(0.23%)
Lithium
45.35
0.11%
Gold
2,666.70
0.5%
Copper
4.13
(0.47%)
Oil
70.09
1.52%
Bitcoin
97,148.60
2.97%
FTSE 100
8,128.31
0.53%
Nikkei 225
38,026.17
(0.85%)
Dow Jones
43,475.71
(0.14%)
Iron Ore
102.15
1.11%
USD/AUD
0.65
0.3%
Hang Seng
19,601.11
(0.23%)
Lithium
45.35
0.11%
Gold
2,666.70
0.5%
Copper
4.13
(0.47%)
Oil
70.09
1.52%
Bitcoin
97,148.60
2.97%
FTSE 100
8,128.31
0.53%
Nikkei 225
38,026.17
(0.85%)
Dow Jones
43,475.71
(0.14%)
Iron Ore
102.15
1.11%
USD/AUD
0.65
0.3%
Hang Seng
19,601.11
(0.23%)
Lithium
45.35
0.11%
Gold
2,666.70
0.5%
Copper
4.13
(0.47%)
Oil
70.09
1.52%
Bitcoin
97,148.60
2.97%
FTSE 100
8,128.31
0.53%
Nikkei 225
38,026.17
(0.85%)
Dow Jones
43,475.71
(0.14%)
Iron Ore
102.15
1.11%
USD/AUD
0.65
0.3%
Hang Seng
19,601.11
(0.23%)
Lithium
45.35
0.11%
Gold
2,666.70
0.5%
Copper
4.13
(0.47%)
Oil
70.09
1.52%
Bitcoin
97,148.60
2.97%
FTSE 100
8,128.31
0.53%
Nikkei 225
38,026.17
(0.85%)
Dow Jones
43,475.71
(0.14%)
Iron Ore
102.15
1.11%
USD/AUD
0.65
0.3%
Hang Seng
19,601.11
(0.23%)
Lithium
45.35
0.11%
Gold
2,666.70
0.5%
Copper
4.13
(0.47%)
Oil
70.09
1.52%
Bitcoin
97,148.60
2.97%
FTSE 100
8,128.31
0.53%
Nikkei 225
38,026.17
(0.85%)
Dow Jones
43,475.71
(0.14%)
Iron Ore
102.15
1.11%
USD/AUD
0.65
0.3%
Hang Seng
19,601.11
(0.23%)
Lithium
45.35
0.11%
Gold
2,666.70
0.5%
Copper
4.13
(0.47%)
Oil
70.09
1.52%
Bitcoin
97,148.60
2.97%
FTSE 100
8,128.31
0.53%
Nikkei 225
38,026.17
(0.85%)
Dow Jones
43,475.71
(0.14%)
Iron Ore
102.15
1.11%
USD/AUD
0.65
0.3%
Hang Seng
19,601.11
(0.23%)
Lithium
45.35
0.11%
Gold
2,666.70
0.5%
Copper
4.13
(0.47%)
Oil
70.09
1.52%
Bitcoin
97,148.60
2.97%
FTSE 100
8,128.31
0.53%
Nikkei 225
38,026.17
(0.85%)
Dow Jones
43,475.71
(0.14%)
Iron Ore
102.15
1.11%
USD/AUD
0.65
0.3%
Hang Seng
19,601.11
(0.23%)
Lithium
45.35
0.11%
Gold
2,666.70
0.5%
Copper
4.13
(0.47%)
Oil
70.09
1.52%
Bitcoin
97,148.60
2.97%
FTSE 100
8,128.31
0.53%
Nikkei 225
38,026.17
(0.85%)
Dow Jones
43,475.71
(0.14%)
Iron Ore
102.15
1.11%
USD/AUD
0.65
0.3%
Hang Seng
19,601.11
(0.23%)
Lithium
45.35
0.11%
Gold
2,666.70
0.5%
Copper
4.13
(0.47%)
Oil
70.09
1.52%
Bitcoin
97,148.60
2.97%
FTSE 100
8,128.31
0.53%
Nikkei 225
38,026.17
(0.85%)
Dow Jones
43,475.71
(0.14%)
Iron Ore
102.15
1.11%
USD/AUD
0.65
0.3%
Hang Seng
19,601.11
(0.23%)

Mesoblast Ltd

MSB

ASX

Mesoblast Limited (MSB) is involved in developing allogeneic (off-the-shelf) cellular medicines for the treatment of severe and life-threatening inflammatory conditions. The Company has leveraged its proprietary mesenchymal lineage cell therapy technology platform to establish a portfolio of late stage product candidates.

Latest Posts

Line Chart with Gradient
Price
$0.000
-0.09 (-5.71%)
At Close (AEST)
Related Companies
AFT PHARMACEUTICALS LIMITED
$AFP
PERCHERON THERAPEUTICS LIMITED
$PER
ZELIRA THERAPEUTICS LIMITED
$ZLD
BCAL DIAGNOSTICS LIMITED
$BDX
RECCE PHARMACEUTICALS LTD
$RCE

Leave a Comment on MSB


Comments for MSB

    Latest Posts

    mesoblast-asx-msb-files-bla-for-ryoncil-with-fda-msb
    Health Care $MSB
    Mesoblast (ASX: $MSB) files BLA for Ryoncil with FDAAnticipates FDA decision by January 2025 for treating pediatric acute graft versus host disease
    October 31, 2024
    mesoblast-asx-msb-secures-up-to-us50-million-for-product-launch-msb
    Health Care $MSB

    Mesoblast (ASX: $MSB) secures up to us$50 million for product launch

    Convertible notes agreement with major shareholder to support commercial strategy for Ryoncil

    September 30, 2024
    mesoblast-asx-msb-pauses-trading-pending-further-announcement-msb
    Health Care $MSB

    Mesoblast (ASX: $MSB) pauses trading pending further announcement

    ASX Listings Compliance - Trading temporarily paused for pending announcement

    March 26, 2024
    mesoblast-asx-msb-submits-detailed-half-year-financial-report-msb
    Health Care $MSB

    Mesoblast (ASX: $MSB) submits detailed half-year financial report

    Highlights net loss of $32.5 million and need for additional funding

    February 29, 2024
    mesoblast-asx-msb-completes-placement-and-institutional-entitlement-offer-msb
    Health Care $MSB

    Mesoblast (ASX: $MSB) completes placement and institutional entitlement offer

    Raises approximately A$55 million through oversubscribed placement and accelerated institutional entitlement offer

    January 15, 2024
    mesoblast-asxmsb-announces-retail-entitlement-offer-msb
    Health Care $MSB

    Mesoblast (ASX:MSB) announces retail entitlement offer

    A$97.0 million to be raised for Phase 3 trials and corporate purposes

    December 19, 2023
    mesoblast-asxmsb-completes-placement-and-institutional-entitlement-offer-msb
    Health Care $MSB

    Mesoblast (ASX:$MSB) completes placement and institutional entitlement offer

    Raises approximately A$55 million through oversubscribed placement and accelerated institutional entitlement offer

    December 10, 2023

    MSB

    $MSB

    Mesoblast (ASX: $MSB) files BLA for Ryoncil with FDA

    Anticipates FDA decision by January 2025 for treating pediatric acute graft versus host disease

    MSB

    $MSB

    Mesoblast (ASX: $MSB) secures up to us$50 million for product launch

    Convertible notes agreement with major shareholder to support commercial strategy for Ryoncil

    MSB

    $MSB

    Mesoblast (ASX: $MSB) pauses trading pending further announcement

    ASX Listings Compliance - Trading temporarily paused for pending announcement

    MSB

    $MSB

    Mesoblast (ASX: $MSB) submits detailed half-year financial report

    Highlights net loss of $32.5 million and need for additional funding

    MSB

    $MSB

    Mesoblast (ASX: $MSB) completes placement and institutional entitlement offer

    Raises approximately A$55 million through oversubscribed placement and accelerated institutional entitlement offer

    MSB

    $MSB

    Mesoblast (ASX:MSB) announces retail entitlement offer

    A$97.0 million to be raised for Phase 3 trials and corporate purposes

    MSB

    $MSB

    Mesoblast (ASX:$MSB) completes placement and institutional entitlement offer

    Raises approximately A$55 million through oversubscribed placement and accelerated institutional entitlement offer

    Related Companies
    INVION LIMITED
    $IVX
    PRESCIENT THERAPEUTICS LIMITED
    $PTX
    CLINUVEL PHARMACEUTICALS LIMITED
    $CUV
    CYNATA THERAPEUTICS LIMITED
    $CYP
    AVITA MEDICAL INC.
    $AVH

    ASX News, First
    & Fast.

    By clicking Subscribe, you agree to our Terms & Conditions

    ASX News, First And Fast.

    By clicking Subscribe, you agree to our Terms & Conditions
    © 2024 Stock Piper.
    All rights reserved

    Blog

    Healthcare
    Materials
    Real Estate
    Consumer Staples
    Consumer Discretionary Brief
    Utilities

    Company

    About us
    Terms of use
    Privacy Policy

    Support

    Contact Support

    Socials

    Facebook
    Twitter
    LinkedIn
    © 2024 Stock Piper. All rights reserved

    Blog

    Healthcare
    Materials
    Real Estate
    Consumer Staples
    Consumer Discretionary Brief
    Utilities

    Company

    About us
    Terms of use
    Privacy Policy

    Support

    Contact Support
    © 2024 Stock Piper. All rights reserved
    Social Media Auto Publish Powered By : XYZScripts.com
    Stock Piper AI Index
    Subscribe
    Join FREE Newsletter

    Stock Piper AI Index Coming Soon!

    Join our Newsletter to gain exclusive insight and be notified once we are live.

    By clicking Subscribe, you agree to our Terms & Conditions

    ASX News, First And Fast.

    Get all the latest market updates straight to your inbox.

    By clicking Subscribe, you agree to our Terms & Conditions